Work

Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks

Year: 2001

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1023/a:1011140818150

Authors: S.R. Alberts, C. Erlichman, J. Sloan, S.H. Okuno, P.A. Burch, J. Rubin, H.C. Pitot, R.M. Goldberg, A.A. Adjei, P.J. Atherton, S.H. Kaufmann

Institution: Mayo Clinic

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Awards: G5087919879, G844520391, Mayo Clinic Comprehensive Cancer Center Support Grant

OpenAlex ID: W2184814799

FWCI: 0.217

Cites: 26

Cited by: 7

Related to: 10